MONECO Advisors LLC bought a new position in shares of Abrdn Healthcare Investors (NYSE:HQH – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 19,367 shares of the financial services provider’s stock, valued at approximately $361,000.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in HQH. Raymond James & Associates grew its position in Abrdn Healthcare Investors by 79.8% during the third quarter. Raymond James & Associates now owns 355,205 shares of the financial services provider’s stock worth $6,614,000 after buying an additional 157,618 shares during the period. Cetera Advisors LLC acquired a new position in Abrdn Healthcare Investors during the first quarter worth about $1,974,000. NINE MASTS CAPITAL Ltd acquired a new position in Abrdn Healthcare Investors during the second quarter worth about $1,350,000. Sanctuary Advisors LLC acquired a new position in Abrdn Healthcare Investors during the second quarter worth about $939,000. Finally, Cetera Investment Advisers grew its position in Abrdn Healthcare Investors by 46.8% during the first quarter. Cetera Investment Advisers now owns 177,208 shares of the financial services provider’s stock worth $2,988,000 after buying an additional 56,521 shares during the period. 32.60% of the stock is currently owned by institutional investors and hedge funds.
Abrdn Healthcare Investors Trading Down 1.0 %
HQH stock opened at $18.16 on Thursday. The company’s 50 day simple moving average is $18.67 and its 200-day simple moving average is $17.88. Abrdn Healthcare Investors has a 12 month low of $14.47 and a 12 month high of $19.79.
Abrdn Healthcare Investors Announces Dividend
Abrdn Healthcare Investors Profile
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Further Reading
- Five stocks we like better than Abrdn Healthcare Investors
- What is the Dogs of the Dow Strategy? Overview and Examples
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Technology Stocks Explained: Here’s What to Know About Tech
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- Investing In Preferred Stock vs. Common Stock
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.